Why 340B Reform Is Vital for Better Care to Underserved Patients

Recent national reporting in The New York Times has shed light on a Senate inquiry into the 340B program, raising concerns about financial incentives, vendor profits, and alignment with its original patient-centered purpose.

The federal 340B program was created to lower costs and improve access to medication, but issues with transparency and accountability have hindered its effectiveness. Lawmakers are seeking financial information to enhance transparency and understanding of the program's operations.

Challenges for Underserved Communities

For many Black Americans and other marginalized populations, barriers like affordability, access, and lack of information persist in navigating the healthcare system. Patient advocates stress the importance of clarity and transparency in programs meant to serve historically excluded communities.

Importance of Trust in 340B

Trust is essential in achieving equity goals within the 340B program. While designed to help nonprofit hospitals care for low-income patients, challenges in reporting and oversight have impacted the realization of benefits for patients.

Reforming and modernizing the 340B program could lead to clearer reporting on savings utilization, increased transparency standards, and better support for patient-facing services. Patient-centered reforms aim to strengthen credibility and sustainability while ensuring equitable healthcare outcomes and access tools for underserved communities.